Eterna Therapeutics Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Eterna Therapeutics Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Eterna Therapeutics Inc. Debt-to-equity for the quarter ending June 30, 2024 was -3.32K %, a 1559% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -3.32K -3.54K -1559% Jun 30, 2024
Q1 2024 3.07K +2.97K +3037% Mar 31, 2024
Q4 2023 859 +760 +768% Dec 31, 2023
Q3 2023 407 +335 +460% Sep 30, 2023
Q2 2023 227 +157 +224% Jun 30, 2023
Q1 2023 97.8 +35.3 +56.5% Mar 31, 2023
Q4 2022 99 +29.2 +41.8% Dec 31, 2022
Q3 2022 72.8 -7.99 -9.89% Sep 30, 2022
Q2 2022 70.2 -5.6 -7.39% Jun 30, 2022
Q1 2022 62.5 -29.6 -32.2% Mar 31, 2022
Q4 2021 69.8 +12.7 +22.3% Dec 31, 2021
Q3 2021 80.8 +17.2 +27.1% Sep 30, 2021
Q2 2021 75.8 -4.48 -5.58% Jun 30, 2021
Q1 2021 92.1 -13.9 -13.1% Mar 31, 2021
Q4 2020 57.1 -66.4 -53.8% Dec 31, 2020
Q3 2020 63.5 -69 -52.1% Sep 30, 2020
Q2 2020 80.3 -49.8 -38.3% Jun 30, 2020
Q1 2020 106 -27.8 -20.8% Mar 31, 2020
Q4 2019 123 -21 -14.6% Dec 31, 2019
Q3 2019 133 -33 -20% Sep 30, 2019
Q2 2019 130 -53.7 -29.2% Jun 30, 2019
Q1 2019 134 -65.7 -32.9% Mar 31, 2019
Q4 2018 145 -54.8 -27.5% Dec 31, 2018
Q3 2018 166 -54.3 -24.7% Sep 30, 2018
Q2 2018 184 -95.2 -34.1% Jun 30, 2018
Q1 2018 200 -155 -43.8% Mar 31, 2018
Q4 2017 199 -259 -56.5% Dec 31, 2017
Q3 2017 220 -247 -52.9% Sep 30, 2017
Q2 2017 279 -86.9 -23.8% Jun 30, 2017
Q1 2017 355 +77.4 +27.9% Mar 31, 2017
Q4 2016 458 +254 +124% Dec 31, 2016
Q3 2016 466 +314 +206% Sep 30, 2016
Q2 2016 366 +251 +219% Jun 30, 2016
Q1 2016 278 +187 +205% Mar 31, 2016
Q4 2015 204 +123 +152% Dec 31, 2015
Q3 2015 153 +79.9 +110% Sep 30, 2015
Q2 2015 115 +46.3 +67.6% Jun 30, 2015
Q1 2015 91 +24 +35.9% Mar 31, 2015
Q4 2014 81.1 +20.4 +33.7% Dec 31, 2014
Q3 2014 72.7 +14.4 +24.7% Sep 30, 2014
Q2 2014 68.5 +7.04 +11.5% Jun 30, 2014
Q1 2014 66.9 +1.1 +1.67% Mar 31, 2014
Q4 2013 60.7 -8.14 -11.8% Dec 31, 2013
Q3 2013 58.3 -16.1 -21.6% Sep 30, 2013
Q2 2013 61.5 -11.4 -15.7% Jun 30, 2013
Q1 2013 65.8 -3.16 -4.58% Mar 31, 2013
Q4 2012 68.8 Dec 31, 2012
Q3 2012 74.4 Sep 30, 2012
Q2 2012 72.9 Jun 30, 2012
Q1 2012 69 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.